Skip to content

Clinical Study on Ayurvedic Formulation in the Management Of Heavy Bleeding

Role Of Kutajashtakleha In The Management Of Asrigdara With Special Reference To Abnormal Uterine Bleeding; A PROOF OF CONCEPT STUDY.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024430
Enrollment
30
Registered
2020-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: one group: Method Of Administration Of Drug ( INTERVENTIONS ) KUTAJASHTAKLEHA DOSE: â?? Kutajashtakleha orally Dose- 10gm twice a day ANUPANA: Godugdha DURATION: Duration- Drug w

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of Asrigrdara any two of the following symptoms: Heavy Menstrual Bleeding ( Amount more than 80 ml ) or Prolonged Menstrual Bleeding(with the duration of bleeding more than 7 days ) Inter Menstrual Bleeding Or Frequent Menstrual Cycle ( Interval Less Than 21 Days) Patient Of Age Group 18 To 45 Years.

Exclusion criteria

Exclusion criteria: Patients Having Bleeding Due To Abortion And Childbirth. Patients Having Coagulation Disorders. Any Type Of Malignancy. Patients Having Sexually Transmitted Diseases( STDs ) Patients Having Any Severe Systemic Diseases. Uterine And Pelvic Pathology Like- Polyps, Endometrial Tuberculosis, Fibroid, Adenomyosis, Pelvic Inflammatory Diseases etc. Patients Using Intrauterine Contraceptive Devices( IUCDs).

Design outcomes

Primary

MeasureTime frame
Achievement of Normal MenstruationTimepoint: Achievement of Normal Menstruation After 60 days ( 2 Menstrual Cycle )

Secondary

MeasureTime frame
Improvement in quality of lifeTimepoint: Improvement in quality of life After 60 days ( 2 Menstraul Cycle )

Countries

India

Contacts

Public ContactKhushboo Jha

National Institute of Ayurveda

baruhunt@gmail.com9492047131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026